Closing the adaptive window: immune–metabolic strategies to constrain melanoma therapy resistance
Melanoma cells respond to therapy not only through selection of pre-existing resistant clones, but also by rapidly engaging reversible adaptive programs that preserve viability under treatment. These programs connect signaling rewiring, metabolic plast…